N/A Completed N=98 Randomized Other

Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms

Tobacco Use

Source: ClinicalTrials.gov NCT01522963 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jul 2017

Primary outcomePrimary: Craving — 5.17; 2.45; -1.05; -1.34 units on a scale

Summary

The purpose of this study is to determine the timeframe (relative to a stress task) that is most effective at attenuating the increase in symptoms of tobacco craving and withdrawal that occur when smokers are presented with stressful situations.

Outcome Measures

Outcome	Result	p-value
PRIMARY Craving	5.17; 2.45; -1.05; -1.34	—
PRIMARY Nicotine Withdrawal Symptoms	2.1; 2.18; 0.32; 0.16	—

Eligibility Criteria

Inclusion Criteria

Smoking an average of at least 10 cigarette per day
General good health

Exclusion Criteria

unstable medical or psychiatric conditions
history of severe motion sickness
women who are pregnant or breast feeding

The investigators will evaluate if there are other reasons why someone may not participate

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01522963). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.